| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/10/2015 | US8952180 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 02/10/2015 | US8952178 Thiophene derivatives |
| 02/10/2015 | US8952171 Compounds and uses thereof for the modulation of hemoglobin |
| 02/10/2015 | US8952169 N-substituted benzamides and methods of use thereof |
| 02/10/2015 | US8952166 Inhibitors of the renal outer medullary potassium channel |
| 02/10/2015 | US8952165 Pharmaceutical composition comprising pyridone derivatives |
| 02/10/2015 | US8952164 R-7-(3-aminomethy-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydo-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/10/2015 | US8952163 Substituted hydroxamic acids and uses thereof |
| 02/10/2015 | US8952162 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 02/10/2015 | US8952160 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity |
| 02/10/2015 | US8952158 Tricyclic compound and use thereof |
| 02/10/2015 | US8952154 Process for the preparation of lapatinib and its ditosylate salt |
| 02/10/2015 | US8952153 One pot process for preparing pemetrexed disodium |
| 02/10/2015 | US8952150 Prostaglandin transporter inhibitors and uses thereof |
| 02/10/2015 | US8952148 Process for the preparation of taurolidine and its intermediates thereof |
| 02/10/2015 | US8952106 Linear polyesteramides from aminophenolic esters |
| 02/10/2015 | US8952075 Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions |
| 02/10/2015 | US8952074 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity |
| 02/10/2015 | US8952073 Estrogenic compounds, process for their production and pharmaceutical uses thereof |
| 02/10/2015 | US8952072 Tannin formulation for treating malnutrition |
| 02/10/2015 | US8952071 (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
| 02/10/2015 | US8952070 Antifungal composition |
| 02/10/2015 | US8952068 Compositions for the treatment of diabetes and pre-diabetes |
| 02/10/2015 | US8952067 Subcutaneous fat reduction |
| 02/10/2015 | US8952066 Pharmaceutical/cosmetic, E.G., anti-acne compositions comprising at least one naphthoic acid compound, benzoyl peroxide and at least one film-forming agent |
| 02/10/2015 | US8952065 Acetylcysteine composition and uses thereof |
| 02/10/2015 | US8952064 Pharmaceutical semi-solid composition of isotretinoin |
| 02/10/2015 | US8952063 Satiety-inducing composition |
| 02/10/2015 | US8952062 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 02/10/2015 | US8952061 Methods and compounds regulating the erythroid response to iron deficiency |
| 02/10/2015 | US8952060 Composition for preventing hair loss or for stimulating hair growth |
| 02/10/2015 | US8952059 Acetyl L-carnitine for the preparation of a medicament for the prevention of painful peripheral neuropathy in patients with type 2 diabetes |
| 02/10/2015 | US8952058 Heterocyclic compounds and methods of use thereof |
| 02/10/2015 | US8952057 Compositions for anorectal use and methods for treating anorectal disorders |
| 02/10/2015 | US8952056 Methods for inhibiting drug degradation |
| 02/10/2015 | US8952055 Membrane fusion inhibitor |
| 02/10/2015 | US8952054 Small molecule inhibitors of MUC1 and methods of identifying the same |
| 02/10/2015 | US8952053 Prodrugs of substituted 1,3-dioxanes and their uses |
| 02/10/2015 | US8952052 Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals |
| 02/10/2015 | US8952051 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 02/10/2015 | US8952050 Modulators of ATP-binding cassette transporters |
| 02/10/2015 | US8952049 Modulators of ATP-binding cassette transporters |
| 02/10/2015 | US8952048 Treatment of immune disorders using kainate receptor antagonists |
| 02/10/2015 | US8952047 Betaine compounds |
| 02/10/2015 | US8952046 Amino acid compositions |
| 02/10/2015 | US8952045 Amino acid compositions |
| 02/10/2015 | US8952044 Antimycotic pharmaceutical composition |
| 02/10/2015 | US8952043 Benzoxepin PI3K inhibitor compounds and methods of use |
| 02/10/2015 | US8952042 FXR (NR1H4) binding and activity modulating compounds |
| 02/10/2015 | US8952041 Modulators of sperm hypermobility and uses thereof |
| 02/10/2015 | US8952040 Pharmaceutical composition for treating coagulation disorder hemorrhage and method using the same |
| 02/10/2015 | US8952039 Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease |
| 02/10/2015 | US8952038 Inhibition of undesired sensory effects by the compound camphor |
| 02/10/2015 | US8952037 Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors |
| 02/10/2015 | US8952036 Benzoic acid derivative MDM2 inhibitor for the treatment of cancer |
| 02/10/2015 | US8952035 Combination of anti-angiogenic substance and anti-tumor platinum complex |
| 02/10/2015 | US8952034 Fused heterocyclic compounds as ion channel modulators |
| 02/10/2015 | US8952033 4-anilinofuro[2,3-b]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same |
| 02/10/2015 | US8952032 Oligomer-opioid agonist conjugates |
| 02/10/2015 | US8952031 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 02/10/2015 | US8952030 Morphinan derivative |
| 02/10/2015 | US8952029 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| 02/10/2015 | US8952028 Methods of treating chemoresistance and relapse in cancer cells |
| 02/10/2015 | US8952027 Inhibitors of syk and JAK protein kinases |
| 02/10/2015 | US8952026 PRMT1 inhibitors and uses thereof |
| 02/10/2015 | US8952025 Multifunctional radical quenchers and their uses |
| 02/10/2015 | US8952024 Herbicidal pyrimidone derivatives |
| 02/10/2015 | US8952023 Compounds useful for treating injuries from warfare agents |
| 02/10/2015 | US8952022 Pure erlotinib |
| 02/10/2015 | US8952021 Compounds for the prevention and treatment of cardiovascular disease |
| 02/10/2015 | US8952020 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| 02/10/2015 | US8952019 Methods of using selective chemotherapeutic agents for targeting tumor cells |
| 02/10/2015 | US8952018 Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors |
| 02/10/2015 | US8952017 Acyclovir formulations |
| 02/10/2015 | US8952016 Substituted xanthine derivatives |
| 02/10/2015 | US8952015 Inhibitors of Bruton's tyrosine kinase |
| 02/10/2015 | US8952013 Controlled release sterile injectable aripiprazole formulation and method |
| 02/10/2015 | US8952012 Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease |
| 02/10/2015 | US8952011 Compositions and methods for the treatment of nasal conditions |
| 02/10/2015 | US8952010 Amino group-containing pyrrolidinone derivative |
| 02/10/2015 | US8952008 Chemical compounds |
| 02/10/2015 | US8952006 Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use |
| 02/10/2015 | US8952005 Substituted 1,3-benzothiazol-2(3H)-ones and [1,3]thiazolo[5,4-B]pyridin-2(1H)-ones as positive allosteric modulators of mGluR2 |
| 02/10/2015 | US8952004 CXCR3 receptor antagonists |
| 02/10/2015 | US8952003 Sterol derivative |
| 02/10/2015 | US8952002 Aminoheteroaryl compounds and preparation method and use thereof |
| 02/10/2015 | US8952001 Amino-heteroaryl derivatives as HCN blockers |
| 02/10/2015 | US8952000 Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| 02/10/2015 | US8951999 Compounds |
| 02/10/2015 | US8951998 Quinoxaline-containing compounds as hepatitis C virus inhibitors |
| 02/10/2015 | US8951997 Substituted isoquinoline derivative |
| 02/10/2015 | US8951996 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 02/10/2015 | US8951995 Use of 24-nor-UDCA |
| 02/10/2015 | US8951994 Method of treating Gaucher disease |
| 02/10/2015 | US8951993 Phosphorus containing compounds as protein kinase inhibitors |
| 02/10/2015 | US8951992 Mycobacterium membrane protease as a target for inhibitors of intrabacterial pH homeostasis |
| 02/10/2015 | US8951991 Polymer mixtures of anionic and cationic polysaccharides and use thereof |
| 02/10/2015 | US8951990 Use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disorders |
| 02/10/2015 | US8951989 Hydrogel tissue adhesive having reduced degradation time |
| 02/10/2015 | US8951987 Certain compounds, compositions and methods |